Transparency data

UK NSC seminars

Updated 28 February 2025

1. Overview

The UK National Screening Committee (UK NSC) hosts seminars for stakeholders to learn from leading experts and to discuss important screening topics.

These events are held over Microsoft Teams and are free to attend. Details of future scheduled seminars are provided below.

2. Upcoming events

There are no upcoming events.

3. Past events

3.1 Multi-cancer detection tests and their implications for screening

This seminar was held on Thursday 27 February 2025. It explored multi-cancer detection tests (MCDs) and their potential use in a screening context.

The event was chaired by Prof Anne Mackie, UK NSC director of Programmes, and featured presentations from Dr Jessica Lloyd, strategic evidence manager within Cancer Research UK’s Evidence and Implementation Department, and UK NSC public health registrar Dr Tom Callender. The presentations were followed by a panel Q&A session.

3.2 Polygenic scores

This seminar was held on Tuesday 6 February, 2024. Professor Anneke Lucassen, Director of the Centre for Personalised Medicine, University of Oxford, presented a discussion of the potential benefits and limitations of using polygenic scores to calculate the overall risk of developing a disease or condition.

See Fascinating insight into potential benefits and limitations of using polygenic scores for a summary of the event and to view the presentation.

3.3 Planning and implementing an in-service evaluation

This seminar was held on 13 November, 2023, and looked at the process of planning and running an in-service evaluation (ISE). Presenters drew from the real-world context of the ISE of screening for severe combined immunodeficiency (SCID) as part of the NHS Newborn Blood Spot (NBS) Screening Programme in England.

See Seminar explains process of planning and running an in-service evaluation for summary of the event and to view the presentations.

3.4 Developing a clinical pathway for modelling of targeted lung cancer screening

This seminar was held on 31 October, 2023, and looked in detail at the evidence and the processes the UK NSC followed in developing a clinical pathway for the modelling of targeted lung cancer screening.

See First UK NSC online seminar a resounding success for summary of the event and to view the presentations.